| Literature DB >> 25959772 |
Siaka Koné1, Thomas Fürst2,3,4,5, Fabienne N Jaeger6,2,3, Emmanuel L J C Esso6, Nahoua Baïkoro6, Kouamé A Kouadio6, Lukas G Adiossan7, Fabien Zouzou6,8, Louis I Boti6, Marcel Tanner2,3, Jürg Utzinger2,3, Bassirou Bonfoh6, Daouda Dao6, Eliézer K N'Goran6,9.
Abstract
BACKGROUND: Current vital statistics from governmental institutions in Côte d'Ivoire are incomplete. This problem is particularly notable for remote rural areas that have limited access to the health system.Entities:
Keywords: Côte d'Ivoire; InterVA-4; cause of death; health and demographic surveillance system; mortality; verbal autopsy
Mesh:
Year: 2015 PMID: 25959772 PMCID: PMC4426287 DOI: 10.3402/gha.v8.27271
Source DB: PubMed Journal: Glob Health Action ISSN: 1654-9880 Impact factor: 2.640
Person-year structure, total number of deaths, and mortality rates by sex and age in the Taabo HDSS, 2009–2011
| Male | Female | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Age (years) | aPYx | aDx | aMx (‰) | aPYx | aDx | aMx (‰) | aPYx | aDx | aMx (‰) |
| <1 | 706 | 87 | 123.2 | 700 | 91 | 130.0 | 1,406 | 178 | 126.6 |
| 1–4 | 6,476 | 100 | 15.4 | 6,475 | 97 | 15.0 | 12,951 | 197 | 15.2 |
| 5–14 | 16,198 | 28 | 1.7 | 14,769 | 27 | 1.8 | 30,967 | 55 | 1.8 |
| 15–49 | 25,617 | 139 | 5.4 | 22,869 | 110 | 4.8 | 48,485 | 249 | 5.1 |
| 50–64 | 3,792 | 62 | 16.4 | 3,176 | 37 | 11.6 | 6,967 | 99 | 14.2 |
| ≥65 | 1,595 | 98 | 61.4 | 1,577 | 72 | 45.7 | 3,173 | 170 | 53.6 |
| All | 54,384 | 514 | 9.5 | 49,566 | 434 | 8.8 | 103,949 | 948 | 9.1 |
aPYx=total person-years lived in the sex-specific cohort from age a to age x.
aDx=total number of deaths in the sex-specific cohort from age a to age x.
aMx (‰)=total mortality rate per 1,000 person-years in the sex-specific cohort from age a to age x.
Idiosyncrasies of InterVA-4 lead to minor rounding errors and explain small differences between the disaggregated data and the summed up totals as presented in this study.
Fig. 1Flow chart detailing the operational result of verbal autopsies in the Taabo HDSS, 2009–2011. The total number of deaths recorded, reasons for exclusion from the present analysis, and the final study sample with complete verbal autopsy data are highlighted.
Deaths with no or incomplete verbal autopsy data by sex and age group in the Taabo HDSS, 2009–2011
| Male | Female | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Age (years) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) |
| <1 | 13 | 1.4 | 18.4 | 16 | 1.7 | 22.9 | 29 | 3.1 | 20.6 |
| 1–4 | 27 | 2.8 | 4.2 | 26 | 2.7 | 4.0 | 53 | 5.6 | 4.1 |
| 5–14 | 7 | 0.7 | 0.4 | 4 | 0.4 | 0.3 | 11 | 1.2 | 0.4 |
| 15–49 | 45 | 4.7 | 1.8 | 32 | 3.4 | 1.4 | 77 | 8.1 | 1.6 |
| 50–64 | 21 | 2.2 | 5.5 | 7 | 0.7 | 2.2 | 28 | 3.0 | 4.0 |
| ≥65 | 15 | 1.6 | 9.4 | 23 | 2.4 | 14.6 | 38 | 4.0 | 12.0 |
| All | 128 | 13.5 | 2.4 | 108 | 11.4 | 2.2 | 236 | 24.9 | 2.3 |
This table summarizes the cases of death that were registered in the Taabo HDSS but that could not or could only incompletely be investigated by means of verbal autopsy. Hence, these cases of death could not be included in the following causes of death analyses.
aDx=total number of deaths in the sex-specific cohort from age a to age x.
% = percentage of all 948 cases of death that were registered in the Taabo HDSS.
aMx (‰)=total mortality rate per 1,000 person-years in the sex-specific cohort from age a to age x.
Idiosyncrasies of InterVA-4 lead to minor rounding errors and explain small differences between the disaggregated data and the summed up totals as presented in this study.
Mortality due to communicable diseases by sex and age group in the Taabo HDSS, 2009–2011
| <1 year | 1–4 years | 5–14 years | 15–49 years | 50–64 years | ≥65 years | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||||||||
| Cause of death | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | |
| Male | |||||||||||||||||||
| Communicable diseases | 34 | 4.8 | 48.6 | 60 | 8.4 | 9.3 | 12 | 1.6 | 0.7 | 53 | 7.5 | 2.1 | 19 | 2.7 | 5.1 | 37 | 5.2 | 23.3 | |
| Acute respiratory infection, including pneumonia | 16 | 2.3 | 22.8 | 10 | 1.5 | 1.6 | 3 | 0.4 | 0.2 | 12 | 1.6 | 0.5 | 8 | 1.1 | 2.1 | 13 | 1.8 | 8.2 | |
| Diarrheal diseases | 3 | 0.4 | 3.9 | 5 | 0.7 | 0.8 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.3 | |
| HIV/AIDS-related death | 5 | 0.7 | 7.1 | 8 | 1.1 | 1.2 | 4 | 0.5 | 0.2 | 9 | 1.3 | 0.4 | 4 | 0.5 | 1.0 | 2 | 0.3 | 1.3 | |
| Malaria | 8 | 1.1 | 11.5 | 33 | 4.6 | 5.0 | 4 | 0.5 | 0.2 | 9 | 1.3 | 0.4 | 2 | 0.3 | 0.5 | 5 | 0.7 | 3.0 | |
| Measles | 1 | 0.1 | 0.8 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Meningitis and encephalitis | 2 | 0.3 | 2.6 | 3 | 0.4 | 0.4 | 0 | 0.0 | 0.0 | 3 | 0.4 | 0.1 | 1 | 0.1 | 0.3 | 0 | 0.0 | 0.0 | |
| Other and unspecified infectious disease | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.2 | 0 | 0.0 | 0.0 | 4 | 0.6 | 0.2 | 1 | 0.1 | 0.3 | 4 | 0.5 | 2.3 | |
| Pulmonary tuberculosis | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 16 | 2.3 | 0.6 | 4 | 0.5 | 0.9 | 12 | 1.7 | 7.4 | |
| Sepsis (non-obstetric) | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.2 | 0.7 | |
| Tetanus | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Female | |||||||||||||||||||
| Communicable diseases | 44 | 6.1 | 62.5 | 58 | 8.1 | 9.0 | 16 | 2.2 | 1.1 | 49 | 6.9 | 2.1 | 14 | 1.9 | 4.3 | 23 | 3.1 | 14.3 | |
| Acute respiratory infection, including pneumonia | 14 | 1.8 | 19.5 | 9 | 1.2 | 1.4 | 5 | 0.7 | 0.3 | 5 | 0.6 | 0.2 | 5 | 0.7 | 1.6 | 10 | 1.4 | 6.6 | |
| Diarrheal diseases | 4 | 0.6 | 5.7 | 4 | 0.5 | 0.6 | 0 | 0.0 | 0.0 | 3 | 0.4 | 0.1 | 1 | 0.1 | 0.3 | 1 | 0.1 | 0.5 | |
| HIV/AIDS-related death | 5 | 0.7 | 7.4 | 12 | 1.6 | 1.9 | 4 | 0.6 | 0.3 | 20 | 2.8 | 0.9 | 3 | 0.5 | 1.1 | 3 | 0.4 | 1.9 | |
| Malaria | 15 | 2.1 | 20.9 | 31 | 4.2 | 4.7 | 5 | 0.6 | 0.3 | 13 | 1.9 | 0.6 | 1 | 0.1 | 0.3 | 4 | 0.5 | 2.3 | |
| Measles | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Meningitis and encephalitis | 4 | 0.6 | 6.3 | 1 | 0.1 | 0.2 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Other and unspecified infectious disease | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 1 | 0.1 | 0.0 | 2 | 0.3 | 0.1 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.6 | |
| Pulmonary tuberculosis | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.2 | 0.1 | 5 | 0.7 | 0.2 | 3 | 0.4 | 0.9 | 4 | 0.5 | 2.2 | |
| Sepsis (non-obstetric) | 1 | 0.1 | 1.2 | 1 | 0.1 | 0.1 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Tetanus | 1 | 0.1 | 1.4 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
aDx=cause-specific number of deaths in the sex-specific cohort from age a to age x.
% = percentage of all 712 cases of death that could be examined with the InterVA-4 tool.
aMx (‰)=cause-specific mortality rate per 1,000 person-years in the sex-specific cohort from age a to age x.
Idiosyncrasies of InterVA-4 lead to minor rounding errors and explain small differences between the disaggregated data and the summed up totals as presented in this study.
Mortality due to non-communicable diseases by sex and age group in the Taabo HDSS, 2009–2011
| <1 year | 1–4 years | 5–14 years | 15–49 years | 50–64 years | ≥65 years | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||||||||
| Cause of death | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | |
| Male | |||||||||||||||||||
| Non-communicable diseases | 8 | 1.1 | 10.8 | 7 | 1.0 | 1.1 | 3 | 0.4 | 0.2 | 17 | 2.4 | 0.7 | 15 | 2.1 | 4.0 | 34 | 4.7 | 21.1 | |
| Acute abdomen | 2 | 0.3 | 2.7 | 3 | 0.4 | 0.4 | 1 | 0.1 | 0.1 | 7 | 1.0 | 0.3 | 5 | 0.8 | 1.4 | 4 | 0.6 | 2.6 | |
| Acute cardiac disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Asthma | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Breast neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Chronic obstructive pulmonary disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Congenital malformation | 3 | 0.5 | 4.9 | 1 | 0.1 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Diabetes mellitus | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.5 | |
| Digestive neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 3 | 0.4 | 0.1 | 4 | 0.5 | 1.0 | 2 | 0.3 | 1.5 | |
| Epilepsy | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 2 | 0.2 | 0.1 | 2 | 0.2 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Liver cirrhosis | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Oral neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 0.1 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.5 | |
| Other and unspecified cardiac disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 0.5 | 9 | 1.3 | 5.6 | |
| Other and unspecified non- communicable diseases | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.2 | 1 | 0.1 | 0.6 | |
| Other and unspecified neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.2 | 0.0 | 1 | 0.1 | 0.3 | 4 | 0.5 | 2.2 | |
| Renal failure | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.5 | |
| Reproductive neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.1 | |
| Respiratory neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.2 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.4 | |
| Severe anemia | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.2 | |
| Severe malnutrition | 2 | 0.3 | 3.2 | 2 | 0.3 | 0.3 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.4 | |
| Stroke | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 0.5 | 5 | 0.6 | 2.9 | |
| Sickle cell with crisis | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Female | |||||||||||||||||||
| Non-communicable diseases | 1 | 0.2 | 1.7 | 4 | 0.5 | 0.6 | 3 | 0.4 | 0.2 | 14 | 2.0 | 0.6 | 11 | 1.5 | 3.4 | 16 | 2.3 | 10.2 | |
| Acute abdomen | 1 | 0.2 | 1.7 | 3 | 0.4 | 0.4 | 1 | 0.1 | 0.1 | 4 | 0.5 | 0.2 | 2 | 0.3 | 0.8 | 5 | 0.7 | 3.1 | |
| Acute cardiac disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.3 | 0 | 0.0 | 0.0 | |
| Asthma | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Breast neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Chronic obstructive pulmonary disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Congenital malformation | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Diabetes mellitus | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.2 | 0.1 | 1 | 0.1 | 0.2 | 2 | 0.2 | 1.1 | |
| Digestive neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 1 | 0.1 | 0.2 | 3 | 0.4 | 1.7 | |
| Epilepsy | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Liver cirrhosis | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 1 | 0.2 | 0.4 | 1 | 0.1 | 0.5 | |
| Oral neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Other and unspecified cardiac disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.2 | 0.1 | 1 | 0.2 | 0.4 | 1 | 0.1 | 0.5 | |
| Other and unspecified non- communicable diseases | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.2 | 0.4 | 1 | 0.1 | 0.6 | |
| Other and unspecified neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.2 | |
| Renal failure | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Reproductive neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.2 | 0.5 | 0 | 0.0 | 0.0 | |
| Respiratory neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Severe anemia | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 1 | 0.1 | 0.3 | 0 | 0.0 | 0.0 | |
| Severe malnutrition | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 2 | 0.3 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.3 | |
| Stroke | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Sickle cell with crisis | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
aDx=cause-specific number of deaths in the sex-specific cohort from age a to age x.
% = percentage of all 712 cases of death that could be examined with the InterVA-4 tool.
aMx (‰)=cause-specific mortality rate per 1,000 person-years in the sex-specific cohort from age a to age x.
Idiosyncrasies of InterVA-4 lead to minor rounding errors and explain small differences between the disaggregated data and the summed up totals as presented in this study.
Mortality due to maternal and neonatal conditions by sex and age group in the Taabo HDSS, 2009–2011
| <1 year | |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Male | Female | Female (15–49 years) | |||||||
|
| |||||||||
| Cause of death | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) |
| Maternal/neonatal | 27 | 3.9 | 38.9 | 23 | 3.2 | 32.7 | 7 | 1.0 | 0.3 |
| Anemia of pregnancy | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 |
| Birth asphyxia | 10 | 1.4 | 14.2 | 6 | 0.9 | 8.8 | 0 | 0.0 | 0.0 |
| Congenital malformation | 3 | 0.4 | 3.8 | 1 | 0.1 | 1.2 | 0 | 0.0 | 0.0 |
| Neonatal pneumonia | 11 | 1.5 | 15.5 | 8 | 1.1 | 11.1 | 0 | 0.0 | 0.0 |
| Neonatal sepsis | 0 | 0.1 | 0.7 | 2 | 0.3 | 3.2 | 0 | 0.0 | 0.0 |
| Obstetric hemorrhage | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 3 | 0.4 | 0.1 |
| Obstructed labor | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Other and unspecified maternal cause of death | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 |
| Other and unspecified neonatal cause of death | 3 | 0.4 | 3.7 | 1 | 0.1 | 1.4 | 0 | 0.0 | 0.0 |
| Pregnancy-induced hypertension | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 0.1 |
| Pregnancy-related sepsis | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 |
| Prematurity | 1 | 0.2 | 1.8 | 5 | 0.7 | 7.0 | 0 | 0.0 | 0.0 |
aDx=cause-specific number of deaths in the sex-specific cohort from age a to age x.
% = percentage of all 712 cases of death that could be examined with the InterVA-4 tool.
aMx (‰)=cause-specific mortality rate per 1,000 person-years in the sex-specific cohort from age a to age x.
Idiosyncrasies of InterVA-4 lead to minor rounding errors and explain small differences between the disaggregated data and the summed up totals as presented in this study.
Mortality due to trauma and injury by sex and age group in the Taabo HDSS, 2009–2011
| <1 year | 1–4 years | 5–14 years | 15–49 years | 50–64 years | ≥65 years | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||||||||
| Cause of death | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) |
| Male | ||||||||||||||||||
| Trauma and injury | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 5 | 0.7 | 0.3 | 14 | 2.0 | 0.6 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.3 |
| Accidental burns and smoke inhalation | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Accidental drowning and submersion | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 2 | 0.3 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Accidental fall | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.2 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Accidental poisoning and noxious substances | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Assault | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 4 | 0.5 | 0.1 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.6 |
| Contact with venomous plants/animals | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Intentional self-harm | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.4 |
| Other and unspecified external cause of death | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Traffic accident | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 0.1 | 2 | 0.3 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Female | ||||||||||||||||||
| Trauma and injury | 0 | 0.0 | 0.0 | 3 | 0.4 | 0.5 | 2 | 0.3 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.3 |
| Accidental burns and smoke inhalation | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.2 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Accidental drowning and submersion | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Accidental fall | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.2 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.5 |
| Accidental poisoning and noxious substances | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Assault | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Contact with venomous plants/animals | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.2 | 1 | 0.1 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Intentional self-harm | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| Other and unspecified external cause of death | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.4 |
| Traffic accident | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
aDx=cause-specific number of deaths in the sex-specific cohort from age a to age x.
%=percentage of all 712 cases of death that could be examined with the InterVA-4 tool.
aMx (‰)=cause-specific mortality rate per 1,000 person-years in the sex-specific cohort from age a to age x.
Idiosyncrasies of InterVA-4 lead to minor rounding errors and explain small differences between the disaggregated data and the summed up totals as presented in this study.
Mortality due to undetermined causes by sex and age group in the Taabo HDSS, 2009–2011
| Male | Female | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Age (years) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) |
| <1 | 8 | 1.0 | 10.7 | 6 | 0.8 | 8.8 | 14 | 1.9 | 9.7 |
| 1–4 | 5 | 0.7 | 0.8 | 5 | 0.8 | 0.8 | 11 | 1.5 | 0.8 |
| 5–14 | 2 | 0.2 | 0.1 | 2 | 0.3 | 0.2 | 4 | 0.5 | 0.1 |
| 15–49 | 9 | 1.3 | 0.4 | 7 | 1.0 | 0.3 | 16 | 2.3 | 0.3 |
| 50–64 | 7 | 0.9 | 1.7 | 5 | 0.7 | 1.7 | 12 | 1.7 | 1.7 |
| ≥65 | 8 | 1.1 | 4.9 | 7 | 0.9 | 4.5 | 15 | 2.1 | 4.7 |
| All | 38 | 5.3 | 0.7 | 33 | 4.7 | 0.7 | 71 | 10.0 | 0.7 |
This table summarizes the mortality due to causes that could not be determined despite complete data from verbal autopsy.
aDx=cause-specific number of deaths in the sex-specific cohort from age a to age x.
% = percentage of all 712 cases of death that could be examined with the InterVA-4 tool.
aMx (‰)=cause-specific mortality rate per 1,000 person-years in the sex-specific cohort from age a to age x.
Idiosyncrasies of InterVA-4 lead to minor rounding errors and explain small differences between the disaggregated data and the summed up totals as presented in this study.
Comparison of the Taabo HDSS mortality data (2009–2011) with other estimates for Côte d'Ivoire
| Taabo HDSS | National comparison data | |
|---|---|---|
| Cause-specific mortality (mortality rate provided per 1,000 person-years in total population) | ||
| Communicable disease | 4.0 | 8.6 |
| Malaria | 1.2 | 0.7 |
| HIV/AIDS-related | 0.8 | 1.6 |
| Non-communicable disease | 1.3 | 7.9 |
| Trauma and injury | 0.3 | 1.2 |
| Adult mortality (all-cause mortality rate provided per 1,000 person-years in adults 15–49 years) | ||
| Crude male mortality | 5.4 | 4.9 |
| Crude female mortality | 4.8 | 5.8 |
| Reproductive health (mortality rate provided per 1,000 live births) | ||
| Maternal mortality | 2.5 | 6.1 |
| Infant mortality | 34.0 | 68.0 |
| Under-five mortality | 94.3 | 108.0 |
| Cause-specific mortality in children under 5 years (distribution of causes of deaths in %) | ||
| Malaria | 29.7 | 16.0 |
| Acute respiratory infections and pneumonia | 16.7 | 15.0 |
| HIV/AIDS | 10.2 | 2.0 |
| Diarrhea-related | 5.5 | 10.0 |
| Intrapartum-related/birth asphyxia | 5.5 | 12.0 |
| Congenital anomalies | 2.7 | 5.0 |
| Prematurity | 2.0 | 13.0 |
| Trauma and injury | 1.0 | 5.0 |
| Neonatal sepsis | 0.7 | 8.0 |
| Neonatal pneumonia | 6.5 | – |
| Measles | 0.3 | 0.0 |
| Other conditions | 18.8 | 14.0 |
Comparison data marked with are from the World Health Statistics 2014, which provides data for 2012 (8).
Comparison data marked with are from the most recent Multiple Indicator Cluster Survey, which provides data collected in late 2011 and early 2012 (9).
Originally, the comparison data were age-standardized and provided as per 100,000 population. For comparison, the data were transformed into crude mortality rates per 1,000 person-years by assuming 1,000 population = 1,000 person-years and ignoring any age standardization.
The cluster of communicable diseases consists of all infectious, contagious, maternal, neonatal, and nutritional conditions, even though the latter three conditions are not communicable. These conditions were grouped together to facilitate comparison with the World Health Statistics 2014, which also uses this grouping (8).
Defined as all-cause mortality in children under 1 year.
Defined as all-cause mortality in children under 5 years.